Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for immunodeficiency-associated lymphoproliferative disease.
7 publications have been identified in PubMed for immunodeficiency-associated lymphoproliferative disease. Research spans Case Report / Case Series (43%), Clinical Trial Publication (29%), and Basic Science / Preclinical (14%).
Yamada M (2026). [PMID: 41560556](https://pubmed.ncbi.nlm.nih.gov/41560556/). *Immunological medicine*. [Case Report / Case Series]
Kuga T (2026). [PMID: 41994749](https://pubmed.ncbi.nlm.nih.gov/41994749/). *Cureus*. [Case Report / Case Series]
Takayama K (2025). [PMID: 40090796](https://pubmed.ncbi.nlm.nih.gov/40090796/). *Clinical lymphoma, myeloma & leukemia*. [Epidemiology / Natural History]
Nagai Y (2025). [PMID: 41273088](https://pubmed.ncbi.nlm.nih.gov/41273088/). *Modern rheumatology*. [Clinical Trial Publication]
Hayashi I (2024). [PMID: 38800284](https://pubmed.ncbi.nlm.nih.gov/38800284/). *Cureus*. [Case Report / Case Series]
Giorgiutti S (2024). [PMID: 38519141](https://pubmed.ncbi.nlm.nih.gov/38519141/). *Life science alliance*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Costagliola G (2024). [PMID: 38770035](https://pubmed.ncbi.nlm.nih.gov/38770035/). *Therapeutics and clinical risk management*. [Clinical Trial Publication]